3 Stocks Under $10 Billion I’m Buying for the Next Decade
1. $HIMS — Hims & Hers Health
Hims is one of the fastest-growing consumer health companies in the US, an industry projected to grow nearly 24% annually through 2030.
The stock is down 50%, mostly due to them no longer being able to mass compound GLP-1 (due to the shortage ending)
But this forced them to diversify into other segments like: sexual health, mental health, dermatology, and women’s healthcare, a segment the CEO says will cross $1 billion on its own by next year.
Hims also launched full-stack lab testing, expanding its ecosystem and increasing LTV as it becomes a truly comprehensive digital health platform.
Management is projecting $6.5B in revenue by 2030. Using a conservative $6B at a 5× price-to-sales multiple implies a $30B market cap. HIMS sits at ~$8B today, meaning the stock has 30% annual return potential over the next five years.
$SOFI five years ago:
• $15/share
• 2.5M members with ~$300M gross profit run-rate
$SOFI today:
• $15/share
• 15.8M members with ~$2.5B gross profit run-rate
Same price. Very different business.
$SOFI SoFi: 𝐑𝐚𝐢𝐬𝐞𝐬 𝟐𝟎𝟐𝟔 𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐚𝐬 𝐑𝐞𝐜𝐨𝐫𝐝 𝐌𝐞𝐦𝐛𝐞𝐫, 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 & 𝐋𝐨𝐚𝐧 𝐆𝐫𝐨𝐰𝐭𝐡 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬
⠀
📊 𝐑𝐞𝐬𝐮𝐥𝐭𝐬
• EPS: $0.12 (Est. $0.11) ✅
• Revenue: $1.22B (Est. $1.13B) ✅
• Adjusted net revenue: $1.21B (+40% YoY); adjusted EBITDA: $358M (+44% YoY)
• Net income: $157M (+61% YoY)
• Record loan originations: $14.8B (+69% YoY); members: 15.8M (+35% YoY); products: 24.4M (+42% YoY)
⠀
🎯 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞
• FY2026 adjusted net revenue: $4.75B–$4.85B (prior: ~$4.66B) ✅
• FY2026 adjusted EBITDA: ~$1.6B (unchanged)
• FY2026 adjusted net income: ~$825M (unchanged)
• FY2026 adjusted EPS: ~$0.60 (unchanged)
⠀
📌 𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬
• Personal loan originations reached a record $10.7B, student loans surged 170% YoY to a record $2.7B and home loans increased 74% YoY to $1.4B.
• Deposits grew to $45.5B, funding ~93% of liabilities and supporting a 5.98% net interest margin.
• Cross-buy continued to accelerate, with 51% of new products opened by existing members, while credit performance remained in line with expectations.
⠀
💬 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲
CEO Anthony Noto said 2026 is becoming a defining year for SoFi, with the company's "everything app" strategy driving record member engagement, product adoption and financial performance, giving management confidence to raise full-year revenue guidance.
@ariaradnia But this also doesn't mean that a stock is a good buy as long as revenue is growing quickly. You can still overpay for growth.
Ideally, you buy a fast growing stock at a fair price!
LEAPS never made sense to me.
If you're trading momentum or sentiment, having a time limit makes sense.
But if you're investing based on fundamentals, why would you want your thesis to be limited by time?
A stock can be undervalued today, execute perfectly for 12 months, and still not move in your direction.